Here, we identified that ACE2 mRNA expression was significantly down-regulated in stage II, III, and IV of breast cancer compared with stage I, indicating that the decrease in ACE2 expression may play a vital role in the development and differentiation of breast cancer. Here, ACE2 is linked to breast carcinoma.